A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,258 followers.

RT @FrontImmunol: New Research: A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fi…

01 Jun 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fi…

01 Jun 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fi…

31 May 2023

Reply Repost Favourite

New Research: A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts: Background Extensive research has established the significant correlations between cancer-associated… #immunology https://t

31 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.